Today: 20 March 2026
Browse Category

NYSE:FIT 5 August 2025 - 8 October 2025

Wall Street’s Wild 48 Hours: Record Highs, AI Deals & Gold’s $4,000 Breakout

Wall Street’s Wild 48 Hours: Record Highs, AI Deals & Gold’s $4,000 Breakout

The S&P 500 and Nasdaq hit record highs before retreating Tuesday as investors took profits; the Dow also slipped. AMD surged about 24% on an OpenAI chip deal, fueling tech gains before valuations cooled. Gold topped $4,000/oz and Bitcoin reached $125,000 amid economic jitters. Fifth Third Bancorp announced an $11 billion deal to buy Comerica, sending Comerica shares up nearly 14%.
Pixel Watch 2 vs Fitbit Sense 2 vs Amazfit Balance: Ultimate 2025 Smartwatch Showdown

Pixel Watch 2 vs Fitbit Sense 2 vs Amazfit Balance: Ultimate 2025 Smartwatch Showdown

Pixel Watch 2 runs Wear OS 4 with a Snapdragon W5+ Gen 1, 2GB RAM, and lasts 36–38 hours per charge. Fitbit Sense 2 offers 6-day battery life, 40+ workout modes, and EDA stress monitoring, but heart-rate accuracy lags in intense training. Amazfit Balance provides 10–14 days of battery, 150+ sport modes, and BIA body composition, but lacks ECG. Prices range from $229–$399 depending on model and features.
Fitbit Charge 6 vs Garmin Vivoactive 6 vs Xiaomi Smart Band 10 Pro – 2025’s Ultimate Fitness Wearable Showdown

Fitbit Charge 6 vs Garmin Vivoactive 6 vs Xiaomi Smart Band 10 Pro – 2025’s Ultimate Fitness Wearable Showdown

Fitbit Charge 6 offers ECG, EDA, and SpO₂ tracking in an aluminum, 50m water-resistant body, priced at $159.95. Garmin Vivoactive 6 features a round AMOLED display, 80+ sport modes, multi-GNSS, and 5 ATM resistance for $299.99. Xiaomi Smart Band 10 Pro has a 1.74-inch AMOLED, 150+ sport modes, GNSS, and costs about $80–$90. Battery life ranges from 5 days (Charge 6) to up to 3 weeks (Band 10 Pro).

Stock Market Today

  • Centene Launches Community Programs Amid Depressed Stock Price: What Investors Should Know
    March 20, 2026, 6:30 AM EDT. Centene Corp subsidiaries have initiated community-focused programs targeting behavioral health, job training, housing support, and diabetes care, aiming to assist underserved populations across major U.S. markets. These efforts come as Centene shares (NYSE:CNC) remain under pressure, with a recent price of $35.57, down 13.7% in the past month and 40.3% over one year. Investors should monitor these initiatives closely for insights into Centene's regulatory relations and potential impact on medical loss ratios and membership retention. Despite current headwinds, the stock trades nearly 17% below analyst targets and is marked as undervalued by Simply Wall St. Key risks include rising costs without clear reimbursement or measurable health outcomes.
Go toTop